A new study found a 52% higher risk for the future development of Parkinson's disease among men with erectile dysfunction.
Long-term use of the drug may predispose men to worsening erectile dysfunction and elevated risk of diabetes and non-alcoholic fatty liver disease.
The risk for developing erectile dysfunction is 15% higher among men with than without gout.
While users had an overall 11% increased risk of melanoma, there wasn't evidence that the drugs cause melanoma.
Diabetic men receiving an inflatable penile prosthesis have a 69% increased risk of device-associated infection compared with non-diabetics.
Oral PDE5 inhibitors improve sperm parameters and can treat erectile dysfunction in men.
Men taking PDE5 lowered their risk of hospitalization and mortality after a heart attack by 33%.
Longer use of finasteride at a dosage of 1.25 mg/day or less among men younger than 42 years is associated with greater risk, study finds.
Chronic periodontitis was associated with 2.2-fold increased odds of ED.
The researchers found that high-sensitivity cardiac troponin I levels were significantly higher in participants with erectile dysfunction than in those without
A recent trial compared the effects of regular grapefruit juice with a low furanocoumarin hybrid grapefruit juice on midazolam.
The prevalence of ED is 30% higher among men who have vitamin D levels below 20 ng/mL versus those with levels of 30 ng/mL or higher.
Prostate cancer was diagnosed in 19.5% of PDE5i users vs 22.7% of nonusers, a statistically insignificant difference.
Low testosterone levels may be a contributing factor.
Researchers say skin cancer in these patients is likely due to more sun exposure.
Alert patients that use of performance-enhancing drugs can lead to erectile dysfunction and infertility.
The chances of erectile function recovery improved when patients received radiation treatment more than 16 months after surgery.
Potency is preserved in 50.4% and 60.8% of patients at 10 years after seed implantation, according to MSSFI and SHIM scores, respectively.
An early, integrated approach led to less deterioration of erectile function after surgery.
Almost quadruple the risk found among Asian men with erectile dysfunction.
Review finds 1.5-3.4 times higher risk of erectile dysfunction among men with periodontitis.
Men undergoing surgery should inform their anesthesiologist about any use of erectile dysfunction drugs.
Many men are unaware of erectile function recovery time and problems with ejaculation.
A combination of exercise and a flavonoid-rich diet can reduce the risk of erectile dysfunction by 21%.
Non-users of 5-alpha-reductase inhibitors had a nearly 2.6 times increased risk of pathologic progression than those who took the drugs.
No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment.
In a small study, 79% of men reported satisfaction with penile prosthesis implantation surgery, supporting its use as an erectile dysfunction treatment.
Small study shows those undergoing radiation therapy had fewer side effects, less fatigue.
Researchers investigate sexual dysfunction post RT for localized prostate cancer.
In a study, mean aldosterone levels increased with severity of ED.
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Not All High-Risk Prostate Cancers Are the Same
- Active Surveillance for Intermediate-Risk PCa May Be Unsafe
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)